DMVF3: quote, dividends and indicators for Rede D1000

Rede d1000 is a pharmaceutical retail company made up of the Drogasmil, Farmalife, Drogarias Tamoio and Drogaria Rosário banners, with common shares traded on B3 under the ticker DMVF3. The company is part of Grupo Profarma, which operates in the distribution of pharmaceutical, personal hygiene and cosmetic products in several Brazilian states. Profarma’s entry into retail took place through acquisitions carried out between 2013 and 2016, which gave rise to the current structure of Rede d1000. In August 2020, the company completed its initial public offering and was listed on B3 as a category A publicly held company, consolidating the holding structure that controls the group’s main retail chains.

Rede d1000’s operational trajectory has been marked by the consolidation of traditional regional brands. The acquisition of CSB Drogarias S.A. in 2013 brought the Drogasmil and Farmalife chains into the company, both with a strong presence in Rio de Janeiro. Drogarias Tamoio, founded in 1953 in São Gonçalo (RJ), had 50% of its capital acquired in 2013 and the remaining 50% in 2016, significantly expanding capillarity in the state. In the same year of 2016, Rede d1000 acquired Drogaria Rosário, focused on the Federal District and Mato Grosso regions. These transactions were accompanied by a turnaround and integration process, with emphasis on improving service levels, reviewing the product portfolio and standardizing store operating processes.

Rede d1000’s business model is focused on retail of pharmaceutical and personal care products, operating a single operating segment. As of December 31, 2025, the company had 300 brick-and-mortar stores distributed across Rio de Janeiro, the Federal District and Mato Grosso, complemented by digital channels and telephone service centers for call center and delivery. The company does not have its own manufacturing process, operating exclusively in the sale of medicines and hygiene, beauty and convenience products, supplied mainly by the Profarma distributor. This vertical integration with the parent company enables daily deliveries, reduces out-of-stock events, lowers working capital needs and allows the capture of administrative synergies, such as the use of a shared services center and lower investment requirements in distribution centers.

Rede d1000’s product portfolio comprises four major groups: medicines, personal hygiene and beauty items, convenience products and exclusive brands. In the medicines segment, the company sells branded drugs (reference and similar drugs subject to medical prescription), generics and OTC/MIPs (over-the-counter drugs), including categories such as painkillers, cold and flu medicines, antacids, among others. In hygiene and beauty, the portfolio includes shampoos, conditioners, dermocosmetics, diapers, baby care products, soaps, oral hygiene items, deodorants, sunscreens, cosmetics and makeup. Convenience products include food items, blood pressure monitors, scales and related items. Since 2014, the company has also been developing its own brands, which include Bem Básico, Bonnevi, Dfresh, GOnutri, Mini Moon, Mise, Nº21, Polimix and Wissen, focused on medicines, vitamins, hygiene, beauty and food products, expanding the mix and allowing greater control over margins and in-store differentiation.

From a market and competitive positioning standpoint, Rede d1000’s operations are concentrated in specific regions, focusing on the states of Rio de Janeiro, Mato Grosso, Goiás and the Federal District, where the Tamoio, Drogasmil, Farmalife and Rosário banners’ stores are located. In around ten years in pharmaceutical retail, the company has achieved a leading position in its main areas of operation, particularly in Rio de Janeiro and the Federal District, with strong brand recognition among the local public. The market, however, is highly fragmented and competitive, with large national and regional chains as well as independent drugstores. Relevant competitors in Rio de Janeiro include Drogaria Pacheco, Raia Drogasil and Drogaria Venâncio, while in the Center-West region competition includes Drogasil, Drogarias Pacheco, Droga Fuji and Pague Menos. In this context, store location, breadth of assortment, product availability, commercial conditions and delivery efficiency are central factors in competing for market share.

The company operates in a sector characterized by relatively resilient consumer demand and specific seasonality. Sales of medicines for respiratory diseases and conditions associated with cold weather increase during winter, while in the summer months the sale of hygiene, beauty, cosmetic and sunscreen products becomes more relevant, driven by greater outdoor leisure and skin care. The first quarter tends to show lower sales volumes, partly due to the smaller number of business days, while the fourth quarter benefits from higher household consumption, especially in the weeks leading up to Christmas. In 2025, Rede d1000’s net revenue reached R$ 2.666 billion, entirely derived from the retail segment of pharmaceutical and personal care products, with no significant concentration in individual customers, indicating a diversified consumer base.

Rede d1000’s operations are enabled by a multichannel service structure. Most brick-and-mortar stores operate with extended hours, from 7 a.m. to 10 p.m., with some units open 24 hours a day. The Drogasmil, Drogarias Tamoio and Drogarias Rosário banners offer sales via phone and WhatsApp, with orders routed to hub stores responsible for picking and delivery. In addition, all brands operate their own e-commerce platforms and apps, with delivery services and “click and collect” options, where purchases are made online and picked up in store. The company also uses superapps such as iFood and Rappi as additional sales channels, reinforcing its digitalization and convenience strategy. In 2025, Rede d1000 reported serving more than 2.6 million consumers per month, with a workforce of over 4,500 employees, reflecting significant scale in its regions of operation.

Rede d1000’s pharmaceutical retail activity is subject to an extensive regulatory environment involving federal, state and municipal legislation. The Ministry of Health and the Brazilian Health Regulatory Agency (ANVISA) are the main regulatory bodies at the federal level, establishing rules for the manufacturing, registration, commercialization and control of medicines and health products. Drugstores must comply with Law 5,991/73 and complementary regulations such as Decree 74,170/74, Law 6,360/76, Law 9,787/99, Decree 8,077/2013 and several ANVISA RDCs, including RDC 44/2009 and RDC 275/2019. Store operations require obtaining a Company Operating Authorization (AFE) from ANVISA, as well as state and municipal sanitary licenses and a Technical Compliance Certificate issued by the Regional Pharmacy Councils, which implies keeping a responsible pharmacist on duty throughout opening hours. The company states that it substantially complies with these requirements, periodically renewing applicable authorizations and licenses. Rede d1000 does not have operations abroad and therefore is not exposed to foreign health regulation in its direct activities, nor does it generate international revenue.

In the environmental, social and governance (ESG) sphere, Rede d1000 develops practices aligned with Grupo Profarma’s sustainability agenda. Starting in 2021, the company established specific guidelines for incorporating environmental, social and governance pillars into its management. The company publishes an annual Sustainability Report based on internationally recognized frameworks such as GRI and SASB, and aligns its strategy with the UN 2030 Agenda, working with priority Sustainable Development Goals defined through a double materiality analysis. Among its social initiatives, the partnership with UNICEF stands out, through microdonations collected in stores, which has resulted in cumulative transfers on the order of tens of millions of reais over a few years, directed to education, health and child and adolescent protection projects in thousands of Brazilian municipalities. The company also carries out social initiatives through Instituto Profarma, focused on food security, distribution of hygiene items, access to health services and professional training, involving hundreds of volunteers and impacting hundreds of thousands of people. In governance, Rede d1000 has implemented projects such as “DNA – Governance in the network,” aimed at suppliers and partners, reinforcing topics such as human rights and the fight against child labor, in addition to strengthening whistleblower channels and expanding the audit committee’s role in its control structure.